-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ATX-101 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATX-101 in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ATX-101 in Non-Small Cell Lung Cancer Drug Details: ATX-101...
-
Product Insights
Hyperoxaluria – Drugs In Development, 2023
Global Markets Direct’s, ‘Hyperoxaluria - Drugs In Development, 2023’, provides an overview of the Hyperoxaluria pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hyperoxaluria, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Primary Hyperoxaluria – Drugs In Development, 2023
Global Markets Direct’s, ‘Primary Hyperoxaluria - Drugs In Development, 2023’, provides an overview of the Primary Hyperoxaluria pipeline landscape. The report provides comprehensive information on the therapeutics under development for Primary Hyperoxaluria, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Primary Hyperoxaluria Type I – Drugs In Development, 2023
Global Markets Direct’s, ‘Primary Hyperoxaluria Type I - Drugs In Development, 2023’, provides an overview of the Primary Hyperoxaluria Type I pipeline landscape. The report provides comprehensive information on the therapeutics under development for Primary Hyperoxaluria Type I, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Exlinkibart in Soft Tissue Sarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Exlinkibart in Soft Tissue Sarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Exlinkibart in Soft Tissue Sarcoma Drug Details: Exlinkibart (LVGN-6051) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – INV-1120 in Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - INV-1120 in Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. INV-1120 in Breast Cancer Drug Details: INV-1120 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PF-07038124 in Atopic Dermatitis (Atopic Eczema)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PF-07038124 in Atopic Dermatitis (Atopic Eczema) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PF-07038124 in Atopic Dermatitis (Atopic Eczema) Drug Details: PF-07038124 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BBP-711 in Primary Hyperoxaluria Type I
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BBP-711 in Primary Hyperoxaluria Type I report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – BBP-711
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry BBP-711 Drug Details BBP-711 is under development for the treatment of primary hyperoxaluria type...
-
Sector Analysis
Country Profile: Fish & Seafood in Spain
The Spanish fish & seafood sector is led by the ‘fresh fish & seafood (counter)’ category in both value and volume terms. The ‘frozen fish & seafood’ category is expected to register fastest value and volume growth during 2017-2022. Hypermarkets & supermarkets is the leading channel for distribution of fish & seafood products in the country. Rigid metal is the most commonly used pack material in the sector, followed by rigid plastics. Calvo, Cantero Trade and Salmon Sur are the...